Opinion on  SanofiAventis (SNY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Good entry point for core stock for any portfolio

Technical Analysis
RSI < 30 and turning. MACD Histogram rising and MACD (7,14,5) about to cross. ADX -DI above 40 for around 3 weeks and now turning.
Thus short-term it seems a good entry point.

Semi-Fundamentals
Great diversification of revenues both by product and regions. Making quick progress into BRIC economies and other promising countries. Strong balance sheet means it can grow either by pipeline investment or acquisition. World population getting older will need more health care.

Warren Buffett  and Martin Whitman both value gurus have opened positions at higher prices than what you can get now. Add to that a 4.5-5% dividend and you get as close as a perfect core stock for any porfolio.